New Delhi November 23,2013:
Biocad is a biopharmaceutical company, is a leader in Russian companies when it comes to the number of trials conducted. The company has a well established laboratory and equipment. Biocad is involved in development of biotechnological products that range from genetic engineering to preclinical testing.
Biocad, this week was successful in obtaining a good manufacturing practice (GMP) certificate in Ukraine. This certificate proves to be important for the company. It confirms that the company’s manufacturing plant in Moscow region meets the standards good manufacturing practice (GMP) norms.
The company deals with biological and biotech products. The areas in which it predominantly focuses include reproductive health, autoimmune health, viral infection and hematology and oncology. The company has clinical research studies being conducted in countries like Russia, Ukraine, India and Belarus. CCI Newswire
